Shaw Christi 4
4 · Kyverna Therapeutics, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Shaw Christi
DirectorExecutive Chairperson
Transactions
- Award
Stock Option (right to buy)
2025-02-14+38,679→ 38,679 totalExercise: $3.03Exp: 2035-02-14→ Common Stock (38,679 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the option shall be fully vested and exercisable on October 30, 2025, subject to the Reporting Person's continuous service to the Issuer as an advisor on and through the vesting date, inclusive.